Anne-Francois de Bourdoncle de Saint Salvy - 21 Sep 2026 Form 4 Insider Report for newcleo plc (NWCL)

Reporting relationship: Director
Issuer ticker: NWCL
Reported as of: 21 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 Sep 2026, 20:06:21 UTC
Source filing: View source filing
Reporting owner signature: /s/ Kateryna Fedorova, attorney-in-fact for Anne-Francois de Bourdoncle de Saint Salvy

Key filing fact

Anne-Francois de Bourdoncle de Saint Salvy filed Form 4 for newcleo plc (NWCL) on 23 Sep 2026.

Key facts

This page summarizes Anne-Francois de Bourdoncle de Saint Salvy's Form 4 filing for newcleo plc (NWCL).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 23 Sep 2026, 20:06.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002147666 Primary reporting owner

de Bourdoncle de Saint Salvy Anne-Francois

Relationship: Director
Address: 55 SOUTH AUDLEY STREET, LONDON, UNITED KINGDOM
Signature: /s/ Kateryna Fedorova, attorney-in-fact for Anne-Francois de Bourdoncle de Saint Salvy
Signature date: 23 Sep 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NWCL transaction Derivative

Stock Options (Right to Buy)

Award

Transaction value
Shares: +3,432
Change %: +10%
Price: $0.000000^*
Shares after: 37,766
Date: 21 Sep 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 3,432
Exercise price: $0.0228
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Reflects the grant of "Company Earnout Bonus Options" to purchase Ordinary Shares in accordance with that certain Business Combination Agreement, dated as of May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd. (the "BCA"). In accordance with the BCA, the Company Earnout Bonus Options will vest and become exercisable as follows: (i) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading days within a 30 trading day period, provided that such price attainment occurs during the period beginning on September 21, 2026 and ending on the five-year anniversary thereof.

Footnote F2

The Company Earnout Bonus Options are fully vested as to service.